Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls

Journal of Molecular Diagnostics

Volumn 11, Issue 3, 2009, Pages 182-185

  Yoon, Kyong Ah ^a   Park, Sohee ^a   Sang, Hee Lee ^a   Jin, Hee Kim ^a   Jin, Soo Lee ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CELL FREE SYSTEM; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SMOKING; STATISTICAL SIGNIFICANCE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DEMOGRAPHY; LUNG TUMOR; MIDDLE AGED; RISK FACTOR; ROC CURVE;

ADULT; AGED; CASE-CONTROL STUDIES; DEMOGRAPHY; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 67149087399     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.080098     Document Type: Article

References (18)

1. Ziegler A, Zangemeister-Wittke U, Stahel RA: Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002, 28:255-271
2. Bremnes RM, Sirera R, Camps C: Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005, 49:1-12
3. Xue X, Zhu YM, Woll PJ: Circulating DNA and lung cancer. Ann NY Acad Sci 2006, 1075:154-164
4. Gormally E, Caboux E, Vineis P, Hainaut P: Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007, 635:105-117
5. Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P: The origin and mechanism of circulating DNA. Ann NY Acad Sci 2000, 906:161-168
6. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001, 313:139-142
7. Gonzalez R, Silva JM, Sanchez A, Dominguez G, Garcia JM, Chen XQ, Stroun M, Provencio M, Espana P, Anker P, Bonilla F: Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol 2000, 11:1097-1104
8. Kopreski MS, Benko FA, Borys DJ, Khan A, McGarrity TJ, Gocke CD: Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. J Natl Cancer Inst 2000, 92:918-923
9. Shao ZM, Wu J, Shen ZZ, Nguyen M: p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res 2001, 7:2222-2227
10. An Q, Liu Y, Gao Y, Huang J, Fong X, Li L, Zhang D, Cheng S: Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett 2002, 188:109-114
11. Wong TS, Kwong DL, Sham JS, Wei WI, Kwong YL, Yuen AP: Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res 2004, 10:2401-2406
12. Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G: p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res 2002, 8:3782-3787
13. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003, 21:3902-3908
14. Herrera LJ, Raja S, Gooding WE, El-Hefnawy T, Kelly L, Luketich JD, Godfrey TE: Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem 2005, 51:113-118
15. Camps C, Sirera R, Bremnes RM, Rodenas V, Blasco A, Safont MJ, Garde J, Juarez A, Caballero C, Sanchez JJ, Taron M, Rosell R: Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer. Anticancer Res 2006, 26:4905-4909
16. Papadopoulou E, Davilas E, Sotiriou V, Georgakopoulos E, Georgakopoulou S, Koliopanos A, Aggelakis F, Dardoufas K, Agnanti NJ, Karydas I, Nasioulas G: Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. Ann NY Acad Sci 2006, 1075:235-243
17. Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S, Pierotti MA: Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann NY Acad Sci 2006, 1075:185-190
18. Kamat AA, Sood AK, Dang D, Gershenson DM, Simpson JL, Bischoff FZ: Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR. Ann NY Acad Sci 2006, 1075:230-234